According to a Research Report Published by Decisions Advisors and Consulting, The Global Acute Myeloid Leukaemia (AML) Market Size was worth around USD 2.95 Billion in 2024 and is predicted to Grow to around USD 8.75 Billion by 2035 with a compound annual growth rate (CAGR) of 10.39% from